Home

James J Schutz

CIK 1367079 · Chief Executive Officer · last filed 2019-01-15

James J Schutz is a Chief Executive Officer who has filed 31 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for SNOAW, was dated Jan 15, 2019. Across all open-market trades the lifetime net is +$201.0K, making them a net buyer over the disclosed history. 32 SEC filings were submitted jointly with Oculus Innovative Sciences, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

31

Lifetime Open-Market Net

$201.0K

Filer Profile

Reported Address
1129 N. MCDOWELL BLVD.
PETALUMA, CA 94954
Related Filers
Oculus Innovative Sciences, Inc. — 32 joint filings, latest 2019-01-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Chief Executive Officer 35,858 — — $30.2K 12 2019-01-15
Sonoma Pharmaceuticals, Inc. (OCLSW) Delisted Chief Executive Officer 10,040 — — $0 1 2016-12-02
Sonoma Pharmaceuticals, Inc. (OCLS) Delisted Chief Executive Officer 6,505 — — $165.8K 17 2016-08-16
Sonoma Pharmaceuticals, Inc. (OCLS.W) Delisted Chief Executive Officer 25,885 — — $5.0K 1 2016-02-29

Recent Filings

31 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-01-15 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted H — $0 EDGAR
2018-07-24 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) — $0 EDGAR
2018-03-08 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Buy (P) +2,473 $9.9K EDGAR
2018-01-03 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +17,211 $0 EDGAR
2017-12-04 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Buy (P) +345 $1.7K EDGAR
2017-11-29 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Buy (P) +400 $2.0K EDGAR
2017-11-27 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Buy (P) +254 $1.3K EDGAR
2017-08-10 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Buy (P) +929 $5.1K EDGAR
2017-06-30 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) +2,406 $0 EDGAR
2017-04-05 Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 31
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.